Sustained maternal human immunodeficiency virus viral load suppression and cascade of human immunodeficiency virus testing among exposed infants in Rwanda

Table 2 Factors associated with sustained viral load suppression among pregnant women living with human immunodeficiency virus in Rwanda

Characteristics	Bivariate		Multivariable
	IRR (95%CI)	P value	Adjusted IRR (95%CI)	P value
Age (years)
18-24	Reference
25-34	0.97 (0.92–1.03)	0.354
35-50	0.98 (0.93–1.03)	0.399
Marital status
Single	Reference		Reference
Married or living together	1.06 (1.01–1.12)	0.0201	1.04 (0.99–1.10)	0.106
Divorced/widowed	1.06 (0.98–1.14)	0.140	1.05 (0.97–1.13)	0.206
Assigned to peer educator
No	Reference
Yes	1.01 (0.97–1.04)	0.741
Human immunodeficiency virus status disclosed
No	Reference		Reference
Yes	1.07 (1.02–1.13)	0.0041	1.06 (1.00–1.11)	0.031
Prior exposure to ART
No	Reference		Reference
Yes	1.04 (1.01–1.08)	0.0261	1.01 (0.97–1.06)	0.609
Pregnant at the start of ART
No	Reference		Reference
Yes	1.04 (1.00–1.08)	0.0401	1.03 (0.98–1.08)	0.233
Number of pregnancies since start
0	Reference		Reference
1-2	0.97 (0.93–1.01)	0.176	0.99 (0.95–1.03)	0.630
≥ 3	0.99 (0.94–1.05)	0.854	0.99 (0.94–1.05)	0.881
Type of health care facility
Clinic	Reference
Health center	1.05 (0.86–1.30)	0.605
Number of health care workers
1-5	Reference		Reference
6-10	1.01 (0.97–1.05)	0.596	1.01 (0.97–1.04)	0.761
≥ 11	1.04 (1.00–1.08)	0.080	1.04 (1.00–1.09)	0.062

¹Indicates significant P value.

ART: Anti-retroviral therapy; IRR: incidence rate ratio; Ref: Reference.